• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Johnson & Johnson Breaks Down Sharply on the Charts So Take Action

Johnson & Johnson has survived some unfortunate news events in the past, but I would not take that as a good technical reason to hold the stock.
By BRUCE KAMICH
Dec 14, 2018 | 03:00 PM EST
Stocks quotes in this article: JNJ

Johnson & Johnson Inc. (JNJ) is part of the club of 30 or a member of the Dow Jones Industrial Average (DJIA). JNJ is off something like $14.44 and it is responsible for around 100 points of the loss of the DJIA today. Ouch. It may be responsible for a lot more according to a Reuters story, but that is for someone else to discuss. Let's stick to the charts and indicators.

In this daily bar chart of JNJ, below, we can see the big high/low range (so far) of today's trading. Prices sliced through the rising 50-day moving average line and is very close to the rising 200-day moving average line. The 200-day line intersects around $132-$133 now and that is the area of the October low and the early August high so we might see support develop there but in this market environment would not bet on it. The daily On-Balance-Volume (OBV) line stalled in November and was already weakening in December. We know that sellers are more aggressive today but isn't it interesting that they were more aggressive this month? The trend-following Moving Average Convergence Divergence (MACD) oscillator crossed to the downside in November for a take profits sell signal and it is close to the zero line now for an outright sell signal.

In this weekly bar chart of JNJ, below, we can imagine that prices are down near the rising 40-week moving average line and we could even close below that line today. The weekly OBV line was moving up from June but that trend could end soon. The weekly MACD oscillator was bullish but is now likely to cross to the downside.

In this Point and Figure chart of JNJ, below, we can see the column of "O's" marking the decline so far today. This chart is projecting a possible downside price target in the $114 area.

Bottom line strategy: we can't do much about the JNJ products we used over the years but we can take action if we own JNJ and it has fallen below our purchase price or stop loss. Yes JNJ has survived other unfortunate news events in the past but I would not take that as a good technical reason to hold the stock.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

Jim Cramer and the AAP team hold a position in Johnson & Johnson for their Action Alerts PLUS Charitable Trust Portfolio . Want to be alerted before Cramer buys or sells JNJ? Learn more now.

TAGS: Investing | Household Products | Pharmaceuticals | Consumer Products

More from Investing

Emergent BioSolutions Turns Bearish, So Beware

Bruce Kamich
Mar 4, 2021 8:27 AM EST

A break in a key support level could precipitate further declines in the life sciences company's shares.

Steepening Yield Curve, All-Star Stocks Beatdown, Fed Speak, S&P Rally?

Stephen Guilfoyle
Mar 4, 2021 7:23 AM EST

Smaller to mid-cap names have fared somewhat better than large cap tech, but make no mistake... there is a circle of life/death here.

Jim Cramer: Playing the Relative Investing Game

Jim Cramer
Mar 4, 2021 6:41 AM EST

Investing can be fun until it turns brutal for what seems to be no reason.

Corrective Action Continues as Support Levels Fall

James "Rev Shark" DePorre
Mar 4, 2021 6:24 AM EST

Dip buyers have lost confidence as selling momentum builds.

With This Market, It's One Way, or the Other

Helene Meisler
Mar 4, 2021 6:00 AM EST

Let's look at this either/or market and why investors are complacent and ... getting angry.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 AM EST PAUL PRICE

    Fabulous news on United Natural Foods (UNFI)

    The major potential risk factor for UNFI, its cont...
  • 08:50 AM EST PAUL PRICE

    Michaels: Close to a Deal?

    It appears that a deal could be announced soon. ...
  • 08:34 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 3/3/2021

    SPX (Long-Term View) The 20 DMA @ 3889 with the ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login